University Hospitals Cleveland Medical Center

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, University Hospitals Cleveland Medical Center sits in the top decile of US sponsors by registered trial count (#142 of 15,742 sponsors by registered trial count).

230 total trials 42 currently recruiting 154 completed later-stage tilt top decile by trial count

University Hospitals Cleveland Medical Center: 230 sponsored US clinical trials, 42 recruiting.

University Hospitals Cleveland Medical Center sponsors 230 registered US clinical trials on ClinicalTrials.gov, 42 of them currently recruiting, and 154 completed. 48 of these trials are in Phase 3-4 (later-stage) and 27 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Bipolar Disorder, with 6 trials.

Top-decile sponsor footprint

University Hospitals Cleveland Medical Center ranks in the top decile of sponsors by registered trial count (#142 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 52/100

154 of 181 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

230 total, page 2 of 5

COMPLETED NA

Efficacy of Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Reduction During Intrauterine Device (IUD) Insertion in Outpatient Gynecology

NCT06335823

COMPLETED NA

eHealth for Breastfeeding Support - the HOTSPOT Trial

NCT06378320

COMPLETED NA

Music Therapy in Patients Undergoing Pancreatic Surgery (MUSIC PUPS)

NCT06123013

COMPLETED NA

CAE for Poorly Adherent Individuals With Schizophrenia

NCT06061952

COMPLETED NA

Music Therapy to Address Patients' Journeys With Chronic Illness, Outcomes, and Readmission

NCT06214325

COMPLETED NA

Reparel Knee Sleeve vs. TED Hose for Post-op Swelling, Pain and Range of Motion After Total Knee Replacement

NCT04751942

COMPLETED NA

BrightPoint Reflectometer Device Study

NCT05616299

COMPLETED NA

Improving Care for Women With Urinary Incontinence (EMPOWER)

NCT05515198

COMPLETED NA

Pilot Evaluation of FAMCOPE-ICU (Family Coping and Emotion Regulation Tool in the ICU)

NCT05408468

COMPLETED NA

Pilot Study of Vitamin K2 (MK-7) and Vitamin D3 Supplementation and the Effects on PASC Symptomatology and Inflammatory Biomarkers

NCT05356936

COMPLETED

Digital PET/CT Using [Ga-68]PSMA vs. [F-18]NaF for Evaluation of Osseous Metastatic Involvement in Prostate Cancer Patients

NCT05527483

TERMINATED Phase 4

Needle-free Delivery of Intralesional Triamcinolone for Pediatric Alopecia Areata

NCT05278858

COMPLETED NA

Pragmatic Impact of Proteomic Risk Stratification in Diabetes Mellitus

NCT05182359

TERMINATED NA

Impact of Surgical Theater's Patient Engagement

NCT05334212

COMPLETED Phase 4

Cycling of Topical Steroids for Treatment of EoE (Eosinopilic Esophagitis)

NCT05444543

COMPLETED NA

Clinical Effectiveness of Body Fat Distribution Imaging in Real-World Practice: The BODY-REAL Study

NCT04763772

COMPLETED Phase 4

Inpatient Penicillin Allergy Delabeling Study

NCT05020327

COMPLETED

Imaging-Guided Vessel Sizing in the Tibial Arteries

NCT04748965

COMPLETED NA

The Adjunctive Use of Lavender and Peppermint Essential Oils

NCT04934969

COMPLETED

Enlarged Vestibular Aqueduct Registry

NCT02798783

COMPLETED NA

Acceptability of Virtual Educational Intervention for Adolescents and Young Adults With Type 1 Diabetes Mellitus

NCT04878419

COMPLETED NA

The RELIEF™ Ureteral Stent - Assessment of Retrograde Urinary Reflux and Distal Coil Bladder Position

NCT03266770

COMPLETED

Immunological Responses of COVID-19 Vaccination

NCT05238467

COMPLETED

Evaluation of Lung T1-MRI in Pediatric Cystic Fibrosis Patients

NCT04994301

COMPLETED Phase 4

Buffered Local Anesthetic

NCT05757648

COMPLETED Early Phase 1

Triamcinolone Acetonide Injections in Mild-to-moderate Chronic Plaque Psoriasis With a Novel Needle-free Drug-delivery System

NCT04410237

COMPLETED NA

Postpartum Hypertension, Tight vs Liberal Control Trial

NCT04592783

COMPLETED

Examining the Effects of Dorsal Column Stimulation on Pain From Lumbar Spinal Stenosis Related to Epidural Lipomatosis.

NCT05811143

COMPLETED NA

Use of Continuous Glucose Monitors in Coronavirus Disease 2019 ICU and Potential Inpatient Settings

NCT05343624

COMPLETED

COVID-19 and Obstetric Transmission

NCT04418557

TERMINATED Phase 4

Evaluating Metabolic Mechanisms of Ertugliflozin in Diabetes & Heart Failure

NCT04071626

COMPLETED Early Phase 1

Zinc Effect on Inflammation and Cardiovascular Risk in HIV

NCT05085834

COMPLETED NA

SELECT2: A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke

NCT03876457

COMPLETED NA

Self-Management in Parents of Technology-Dependent Children

NCT04105244

TERMINATED NA

Evaluating Parent Engagement, Attachment, Stress, and Satisfaction With Remote Rounding in the NICU

NCT04373915

COMPLETED Phase 3

Ketorolac as an Adjuvant Agent for Postoperative Pain Control Following Arthroscopic ACL Surgery

NCT04246554

COMPLETED NA

Belun Ring Validation Study for Assessment of Obstructive Sleep Apnea

NCT03997916

COMPLETED

Glycemic Characterization and Pancreatic Imaging Correlates in Cystic Fibrosis

NCT03961516

COMPLETED Phase 3

Ketorolac as an Adjuvant Agent for Postoperative Pain Control Following Arthroscopic Meniscus Surgery

NCT04246541

COMPLETED

Mitochondrial Biomarkers in Huntington's Disease

NCT04515550

COMPLETED NA

Air Pollution: Strategies for Personalized Intervention to Reduce Exposure

NCT03744871

COMPLETED

Misfolded Proteins in the Skin of People With Parkinson's Disease and Other Parkinsonism

NCT04518059

COMPLETED Phase 3

Oral Ketorolac for Arthroscopic Rotator Cuff Repair

NCT03967847

COMPLETED

Microbiome and Mycobiome Registry of Volunteers With and Without Autism Spectrum Disorder

NCT03819439

COMPLETED NA

Prematurity Education in High Risk Pregnancies

NCT03772080

COMPLETED NA

Mobile Application and Pregnant Patient Knowledge

NCT03452215

COMPLETED NA

MUSic Therapy to Improve Quality Of Life in Sickle Cell Disease (MUSIQOLS)

NCT03556657

COMPLETED Phase 2

Tamsulosin vs Placebo to Prevent Postoperative Urinary Retention in Female Pelvic Reconstructive Surgery

NCT03524339

TERMINATED Phase 4

Mineralocorticoid Receptor Antagonism Clinical Evaluation in Atherosclerosis Add-On

NCT03597035

COMPLETED NA

Effect of Protein Intake on Post Prandial Hyperglycemia in Children and Adolescents With Type1 Diabetes Mellitus

NCT04655131

← Previous Page 2 of 5 Next →

Phase Distribution

PhaseTrial count
Phase 1 14
Phase 2 13
Phase 3 16
Phase 4 32

Where University Hospitals Cleveland Medical Center enrollment is open (later-stage tilt)

42 recruiting of 230 indexed (18% open); 154 completed (67%).

Phase mix: 48 late (III/IV) vs 27 early (I/II) (later-stage heavy).

Top condition: Bipolar Disorder (6 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University Hospitals Cleveland Medical Center: open-pipeline peers nationwide

Peers matched on 230 registered trials and 18% open enrollment, not the therapeutic-area sidebar.

University Hospitals Cleveland Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 050100150200250 10%12%14%16%18%20% Total trials Recruiting share University Hospitals Cleveland Medical CenterBrown UniversityUniversity of IowaGeorgetown UniversityHenry Ford Health SystemBurke Medical Research InstituteGrand Valley State UniversityImunonInventisBio Co.
University Hospitals Cleveland Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University Hospitals Cleveland Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 230 trials (± recruiting share)

Sponsors near 18% open enrollment (± trial volume)

What to do with this University Hospitals Cleveland Medical Center page

230 registered trials is a research-attention snapshot, not an endorsement of University Hospitals Cleveland Medical Center or any single study.

  • 42 of University Hospitals Cleveland Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Bipolar Disorder is the condition University Hospitals Cleveland Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Bipolar Disorder trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University Hospitals Cleveland Medical Center pipeline card: 230 registered trials from official public datasets.Report a data error.